Wellington Management Group
LKFT

Wellington Management Group’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Wellington Management Group’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-345,050
Closed -$8.55M – 1959
2024
Q2 		$8.55M Sell
345,050
-129,833
-27% -$3.68M ﹤0.01% 1197
2024
Q1 		$15.3M Sell
474,883
-20,334
-4% -$756K ﹤0.01% 1009
2023
Q4 		$20.1M Buy
495,217
+18,552
+4% +$683K ﹤0.01% 938
2023
Q3 		$16.5M Sell
476,665
-48,064
-9% -$1.87M ﹤0.01% 976
2023
Q2 		$21.3M Buy
524,729
+109,114
+26% +$4.45M ﹤0.01% 929
2023
Q1 		$16.1M Sell
415,615
-31,752
-7% -$1.31M ﹤0.01% 990
2022
Q4 		$19.9M Sell
447,367
-10,256
-2% -$432K ﹤0.01% 919
2022
Q3 		$19.5M Buy
457,623
+430,429
+1,583% +$22.1M ﹤0.01% 913
2022
Q2 		$1.52M Buy
27,194
+10,619
+64% +$630K ﹤0.01% 1594
2022
Q1 		$1.03M Buy
16,575
+293
+2% +$17.9K ﹤0.01% 1731
2021
Q4 		$898K Buy
+16,282
New +$849K ﹤0.01% 1822
2021
Q1 		– Sell
-49,353
Closed -$4.88M – 2126
2020
Q4 		$4.88M Sell
49,353
-614
-1% -$75.1K ﹤0.01% 1332
2020
Q3 		$7.09M Sell
49,967
-6,923
-12% -$1.15M ﹤0.01% 1187
2020
Q2 		$11.2M Sell
56,890
-72,043
-56% -$14.9M ﹤0.01% 1042
2020
Q1 		$25.3M Sell
128,933
-165,838
-56% -$35.7M 0.01% 820
2019
Q4 		$61M Sell
294,771
-49,024
-14% -$9.06M 0.01% 710
2019
Q3 		$52.5M Sell
343,795
-298
-0.1% -$48.8K 0.01% 714
2019
Q2 		$44.4M Buy
344,093
+3,699
+1% +$439K 0.01% 791
2019
Q1 		$40.1M Sell
340,394
-16,681
-5% -$1.68M 0.01% 817
2018
Q4 		$32.8M Buy
357,075
+161,195
+82% +$16.3M 0.01% 850
2018
Q3 		$22M Sell
195,880
-56,108
-22% -$5.93M ﹤0.01% 1054
2018
Q2 		$23.2M Sell
251,988
-1,140
-0.5% -$111K 0.01% 1040
2018
Q1 		$25.3M Sell
253,128
-15,198
-6% -$1.64M 0.01% 997
2017
Q4 		$25.2M Sell
268,326
-74,328
-22% -$7.03M 0.01% 999
2017
Q3 		$34.9M Sell
342,654
-54,067
-14% -$4.72M 0.01% 871
2017
Q2 		$30.4M Sell
396,721
-61,367
-13% -$5.16M 0.01% 887
2017
Q1 		$39.5M Buy
458,088
+39,729
+9% +$2.86M 0.01% 806
2016
Q4 		$26.9M Sell
418,359
-50,623
-11% -$3.12M 0.01% 918
2016
Q3 		$30.3M Sell
468,982
-298,597
-39% -$16.8M 0.01% 847
2016
Q2 		$42.6M Sell
767,579
-32,620
-4% -$1.64M 0.01% 724
2016
Q1 		$33.5M Buy
800,199
+177,656
+29% +$8.24M 0.01% 781
2015
Q4 		$39.1M Buy
622,543
+285,460
+85% +$14.6M 0.01% 742
2015
Q3 		$13.7M Buy
+337,083
New +$19.4M ﹤0.01% 1080

Other funds holding LKFT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Wellington Management Group's LKFT Position: Q3 2024 in Review

Wellington Management Group sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q3 2024, closing a stake of 345,050 shares — an estimated $8.55M sold.

Wellington Management Group first reported a position in LKFT in Q3 2015 and held it in 33 quarters. The position peaked at $61M in Q4 2019. 79 funds tracked by Wall St. Rank hold LKFT as of Q3 2024.

  • Wellington Management Group reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Wellington Management Group sold 345,050 Lakefront Biotherapeutics American Depositary Shares shares in Q3 2024, an estimated $8.55M.
  • Wellington Management Group first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2015 and held it in 33 quarters.
  • Wellington Management Group's Lakefront Biotherapeutics American Depositary Shares position peaked at $61M in Q4 2019.
  • 79 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q3 2024.

Based on Wellington Management Group's 13F filing for Q3 2024, filed 14 Nov 2024.